Submitted by Anonymous (not verified) on 22 December 2025 - 14:20
Human medicines European public assessment report (EPAR): Osvyrti, denosumab, Date of authorisation: 26/05/2025, Revision: 1, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Osvyrti, denosumab, Date of authorisation: 26/05/2025, Revision: 1, Status: Authorised